72F-12566-34011
2 vaccinations
2 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 984 / WA
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Registered in v-safe
-
2021-01-03
Dose 1 — Moderna
- 2021-01-03
- 2021-01-04
-
2021-01-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2021-01-06
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-09
- 2021-01-10
-
2021-01-17
Survey response — day 14, dose 1MedDRA: Ageusia, Asthma, Rash, SARS-CoV-2 test negative — Feeling: FairFree text: Some mild asthma-like symptoms and a skin rash similar to the one I have only experienced alongside taste loss April, 2020, into May, 2020, when I had a negative nasal swab test 3 days after onset of symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-24
-
2021-01-31
Dose 2 — Moderna
- 2021-02-07
- 2021-02-14
- 2021-02-21
- 2021-02-28
- 2021-03-07
- 2021-03-16
-
2021-05-02
Survey response — 3 months, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: I've had ongoing (mild to severe) digestive issues since my first dose that became worse aftrr my second and at times life-disrupting (unable to work); also unique skin eruptions like I had in spring of 2020 alongside loss of taste w/neg nasal swab.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Moderna | |
| 2 | 2021-01-31 | Moderna |
Free text
Release 2 — day 14, dose 1
Symptoms: Some mild asthma-like symptoms and a skin rash similar to the one I have only experienced alongside taste loss April, 2020, into May, 2020, when I had a negative nasal swab test 3 days after onset of symptoms.
Release 8 — 3 months, dose 2
Symptoms: I've had ongoing (mild to severe) digestive issues since my first dose that became worse aftrr my second and at times life-disrupting (unable to work); also unique skin eruptions like I had in spring of 2020 alongside loss of taste w/neg nasal swab. cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release